Pokaż uproszczony rekord

dc.contributor.authorOlejnik, Alicja
dc.contributor.authorŻółtaszek, Agata
dc.date.accessioned2022-09-28T08:32:21Z
dc.date.available2022-09-28T08:32:21Z
dc.date.issued2022-09
dc.identifier.urihttp://hdl.handle.net/11089/43438
dc.description.abstractThe wealth–health relationship is not unambiguous and constant. Indeed, a higher level of wealth affects individual and population health in two opposite ways. Increased risk factors raise the probability of some diseases especially non-communicable diseases (NCDs). Conversely, better healthcare and awareness reduce the chances of developing these diseases or raise the likelihood of treatment and cure. Therefore, the overall impact on health or the ‘net effect’ of wealth (positive or negative) may be challenging to determine. Moreover, this effect may not be fixed for different income groups. Thus, it states to reason that there may exist an ‘affluence point’ changing the predominant impact of wealth (positive/negative), which we will refer to as the ‘health economic threshold’. This paper aims to assess and quantify the hard-to-grasp overall impact of prosperity on the mortality of selected NCDs in European regions. In particular, we attempt to estimate both the net effect of affluence and the health economic threshold of GDP-mortality relationship, by developing a dedicated analytical tool. The original idea is based on joinpoint regression and forecasting methods. To our knowledge, no such study has been performed in health economics. Our results show that in the case of most investigated diseases in more impoverished regions, mortality rises with prosperity. After crossing the health economic threshold of around 20 thousand euros per capita, the trend changes (it stabilises or reverses).pl_PL
dc.language.isoenpl_PL
dc.publisherUniwersytet Łódzki, Wydział Ekonomiczno-Socjologicznypl_PL
dc.relation.ispartofseriesLodz Economics Working Papers;
dc.subjecthealth economicspl_PL
dc.subjecthealth economic thresholdpl_PL
dc.subjectjoinpoint regressionpl_PL
dc.subjectnet effect of affluencepl_PL
dc.subjectregional studiespl_PL
dc.subjectnon-communicable diseasespl_PL
dc.titleThe Net Effect of Wealth on Health for Non-Communicable Diseasespl_PL
dc.typeWorking Paperpl_PL
dc.page.number28pl_PL
dc.contributor.authorAffiliationUniversity of Lodzpl_PL
dc.contributor.authorAffiliationUniversity of Lodzpl_PL
dc.referencesAnselin L. (1988). Spatial Econometrics: Methods and Models. Kluwer Academic Publications, Dordrecht.pl_PL
dc.referencesBenson, C., Glasgow, S. M. (2014). Noncommunicable Disease as a Security Issue. from: Routledge Handbook of Global Health Security Routledge. (https://www.routledgehandbooks.com/doi/10.4324/9780203078563.ch15) [accessed: 21.08.2017].pl_PL
dc.referencesBreast cancer burden in EU-27. (2020). ECIS, European Union.pl_PL
dc.referencesColorectal cancer burden in EU-27. (2021). ECIS, European Union.pl_PL
dc.referencesCrispo A., Barba M., Malvezzi M., Arpino G., Grimaldi M., Rosso T., Esposito E., Sergi D., Ciliberto G., Giordano A., Montella M. (2013). Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, southern Italy: results from a joinpoint regression analysis. Cancer Biology and Therapy, 14 (12), pp. 1113-1122.pl_PL
dc.referencesDanaei G., Singh G.M., Paciorek K.J., Lin J.K., Cowan M.J., Finucane M.M., Farzadfa F., Stevens G.A., Riley L.M., Lu Y., Rao M., Ezzati M. (2013). The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with Macroeconomic Variables in 1980 and 2008,.Circulation, 127, pp. 1493–1502, doi:10.1161/CIRCULATIONAHA.113.001470.pl_PL
dc.referencesDyvesether S., Nordentoft M., Forman J., Erlangsen A. (2018). Joinpoint regression analysis of suicides in Denmark during 1980–2015. Danish Medical Journal, 65 (4), pp. 1-5.pl_PL
dc.referencesEurostat Database https://ec.europa.eu/eurostat/data/database [accessed: 15.02.2021].pl_PL
dc.referencesFarrell C. (2010). Mental Disorders. ABDO Publishing Company, North Mankato, Minnesota.pl_PL
dc.referencesHinkley D.V. (1971). Inference in Two-Phase Regression. Journal of the American Statistical Association, 66: 336, pp. 736-743, DOI: 10.1080/01621459.1971.10482337.pl_PL
dc.referencesJiang Z., Qiu Z., Hatcher J. (2010). Joinpoint Trend Analysis of Cancer Incidence And Mortality Using Alberta Data. Cancer Surveillance, Surveillance and Health Status Assessment, Alberta Health Services, pp. 1-45.pl_PL
dc.referencesKim D., Chen Z., Zhou L-F., Huang S-X. (2018). Air pollutants and early origins of respiratory diseases. Chronic Diseases and Translational Medicine ,4, pp. 75-94.pl_PL
dc.referencesLabarthe D. (2011). Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge. Jones & Bartlett Publishers, Sundbury, Massachusetts.pl_PL
dc.referencesLink K. (2007). Understanding New, Resurgent, and Resistant Diseases: How Man and Globalization Create and Spread Illness. Greenwood Publishing Group, Westport, London.pl_PL
dc.referencesLopez-Campos J.L., Ruiz-Ramos M., Soriano J.B., (2014). Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respiratory Medicine, 2 (1), pp. 54- 62.pl_PL
dc.referencesMoran P. (1950). Notes on Continuous Stochastic Phenomena, Biometrika, 37, pp. 17–23.pl_PL
dc.referencesOffer A. (2006). The Challenge of Affluence: Self-Control and Well-Being in the United States and Britain Since 1950. Oxford University Press, Oxford.pl_PL
dc.referencesOlejnik J., Olejnik A. (2020). Metody stochastyczne w ekonometrii przestrzennej. Nowoczesna analiza asymptotyczna (Stochastic methods in spatial econometrics. Modern asymptotic analysis). Wydawnictwo Uniwersytetu Łódzkiego.pl_PL
dc.referencesNCD Alliance: Mental Health and Neurological Disorders https://ncdalliance.org/why-ncds/ncd- management/mental-health-and-neurological-disorders [accessed: 31.07.2021].pl_PL
dc.referencesQiu D., Katanoda K., Marugame T., Sobue T. (2009). A joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958–2004). International Journal of Cancer, 124 (2), pp. 443-448.pl_PL
dc.referencesRegional Innovation Monitor Plus - South Transdanubia, https://ec.europa.eu/growth/tools-databases/regional- innovation-monitor/base-profile/south-transdanubia-0 [accessed: 09.08.2021].pl_PL
dc.referencesReport of Eurostat's task force: Revision of the European Standard Population 2013 (http://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8- b23d-5e8fa09b3f8f) [accessed: 25.06.2016].pl_PL
dc.referencesSmeester, L., Yosim, A. E., Fry, R. C. (2015). Chemical hazards. from: Routledge Handbook of Water and Health, Routledge. https://www.routledgehandbooks.com/doi/10.4324/9781315693606.ch10 [accessed: 21.09.2017] .pl_PL
dc.referencesSprent, P. (1961). Some Hypotheses Concerning Two Phase Regression Line. Biometrics, 17 (4), pp. 634-645, doi:10.2307/2527862 .pl_PL
dc.referencesSylwester, D. L. (1965). On maximum likelihood estimation for two-phase linear regression. Technical report prepared under the auspices of public health service grant USPRS=5TIGM 25-07 .pl_PL
dc.referencesThe World Bank Data .https://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD [accessed:01.07.2021].pl_PL
dc.referencesVanitallie, T. B. (2002). Stress: A risk factor for serious illness. Metabolism, Volume 51, Issue 6, Part B, pp. 40– 45, https://doi.org/10.1053/meta.2002.33191 .pl_PL
dc.referencesWhat is a neurological problem? https://www.brainandspine.org.uk/information-and-support/what-is-a- neurological-problem/ [accessed: 31.07.2021].pl_PL
dc.referencesWHO: Asthma https://www.who.int/news-room/fact-sheets/detail/asthma [accessed: 31.07.2021].pl_PL
dc.referencesWHO: Barriers to early cancer diagnosis and treatment, ps://www.euro.who.int/en/health- topics/noncommunicable-diseases/cancer/policy/screening-and-early-detection/barriers-to-early-cancer- diagnosis-and-treatment [accessed: 09.08.2021].pl_PL
dc.referencesWHO: Chronic respiratory diseases https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1 [accessed: 31.07.2021].pl_PL
dc.referencesWHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/table [accessed: 01.07.2021].pl_PL
dc.referencesWHO Factsheet: Cardiovascular diseases (CVDs), 11 Jun 2021, https://www.who.int/news-room/fact- sheets/detail/cardiovascular-diseases-(cvds) [accessed: 30.07.2021].pl_PL
dc.referencesWHO Factsheet for World Mental Health Day 2018, Regional Office for Europe 2018 (https://www.who.int/mental_health/world-mental-health-day/2018/en/) [accessed: 02.11.2019].pl_PL
dc.referencesWHO Factsheet: Mental health: Fact sheet, Regional Office for Europe 2019 (http://www.euro.who.int/en/health-topics/noncommunicable-diseases/mental-health/data-and-resources/fact- sheet-mental-health-2019) [accessed: 02.11.2019].pl_PL
dc.referencesWHO Report: Global action plan for the prevention and control of non-communicable diseases 2013-2020. (2013). World Health Organization. Geneva.pl_PL
dc.referencesWHO Global Health Observatory (GHO) (https://www.who.int/gho/ncd/en/) [accessed: 03.11.2019].pl_PL
dc.referencesWHO Mental health https://www.who.int/health-topics/mental-health#tab=tab_1 [accessed: 31.07.2021].pl_PL
dc.referencesWHO Report: ATLAS on Substance Use (2010), Chapter 1: Psychoactive substance use: epidemiology and burden of disease, http://www.who.int/substance_abuse/publications/treatment/en/ [accessed: 25.06.2016].pl_PL
dc.referencesWHO Report: Classification of diabetes mellitus. (2019). World Health Organization. Geneva.pl_PL
dc.referencesWHO Report: Climate change and human health : risks and responses. (2003). ed. A. J. McMichael. (https://www.who.int/globalchange/publications/climchange.pdf) [accessed: 02.11.2019]pl_PL
dc.referencesWHO Report: Global action plan for the prevention and control of non-communicable diseases 2013-2020. (2013) (https://www.who.int/nmh/publications/ncd-action-plan/en/) [accessed: 02.11.2019]pl_PL
dc.referencesWHO Report: Global report on diabetes. (2016). World Health Organization. Geneva.pl_PL
dc.referencesWHO Report: Global Report on Urban Health (2016), http://www.who.int/kobe_centre/publications/urban- global-report/en/ [accessed: 25.06.2016].pl_PL
dc.referencesWHO Report: Global status report on non-communicable diseases 2010 (2011). http://www.who.int/nmh/publications/ncd_report2010/en/ [accessed: 25.06.2016].pl_PL
dc.referencesWHO Report: Improving mental health through integration with NCD management and prevention, Regional Office for Europe 2019 (http://www.euro.who.int/en/health-topics/noncommunicable-diseases/mental- health/data-and-resources/infographic-improving-mental-health-through-integration-with-ncd-management- and-prevention-2019) [accessed: 02.11.2019]pl_PL
dc.referencesWHO Report: Mental health atlas 2017. (2018). World Health Organization. Geneva.pl_PL
dc.referencesWHO Report: Neurological disorders. Public health challenges. (2006). World Health Organization. Geneva.pl_PL
dc.referencesWHO Report: Noncommunicable Diseases Progress Monitor, 2017. (2017). World Health Organization. Geneva. (https://www.who.int/nmh/publications/ncd-progress-monitor-2017/en/) [accessed: 02.11.2019].pl_PL
dc.referencesWHO Report: Noncommunicable diseases country profiles 2018. (2018). World Health Organization. Geneva (https://www.who.int/nmh/publications/ncd-profiles-2018/en/) [accessed: 02.11.2019].pl_PL
dc.referencesWHO Report: Noncommunicable diseases country profiles 2020. (2020). World Health Organization. Geneva (https://apps.who.int/iris/bitstream/handle/10665/330805/9789240000490-eng.pdf)[accessed: 23.08.2021].pl_PL
dc.referencesWHO report on cancer: setting priorities, investing wisely and providing care for all. (2020). World Health Organization. Geneva.pl_PL
dc.referencesWHO: Unknown author (2010). The weight of affluence. Bulletin of the World Health Organization, 88 (2), pp. 86 - 87. World Health Organization. http://dx.doi.org/10.2471/BLT.10.020210 .pl_PL
dc.referencesWHO updated Appendix 3 of the WHO Global NCD Action Plan 2013-2020 (2017): Tackling NCDs: 'best buys' and other recommended interventions for the prevention and control of non-communicable diseases. World Health Organization. https://apps.who.int/iris/handle/10665/259232. [accessed: 02.11.2019].pl_PL
dc.referencesWHO updates Cardiovascular Risk Charts, 2 Sep 2019, https://www.who.int/news/item/02-09-2019-who- updates-cardiovascular-risk-charts [accessed: 30.07.2021].pl_PL
dc.referencesWilkins E., Wilson L., Wickramasinghe K., Bhatnagar P., Leal J., Luengo-Fernandez R., Burns R., Rayner M., Townsend N. (2017). European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels.pl_PL
dc.referencesWilson L., Bhatnagar P., Townsend N. (2017). Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: joinpoint regression analysis. Popululation Health Metrocs, 15 (1), p. 23.pl_PL
dc.referencesWolf J., Prüss-Ustün A., Ivanov I., Mudgal S., Corvalán C., Bos R. et al. (2018) Preventing disease through a healthier and safer workplace. Geneva, World Health Organization, https://apps.who.int/iris/handle/10665/272980 [accessed: 02.11.2019].pl_PL
dc.referencesYu B., Huang L., Tiwari R.C., Feuer E.J., Johnson K.A. (2009),.Modelling population-based cancer survival trends by using join point models for grouped survival data, Journal of Royal Statictical Scoiety, Statytstical Society, Ser. A, 172 (2), pp. 405-425.pl_PL
dc.referencesŻółtaszek A., Olejnik A. (2017). Economic Development and the Spread of Diseases of Afluence in EU Regions. Acta Universitatis Lodziensis Folia Oeconomica 5(331), pp.23-37, DOI: http://dx.doi.org/10.18778/0208-6018.331.02 .pl_PL
dc.relation.volume2pl_PL
dc.disciplineekonomia i finansepl_PL


Pliki tej pozycji

Thumbnail

Pozycja umieszczona jest w następujących kolekcjach

Pokaż uproszczony rekord